Eduardo Mysler, Gerd R Burmester, Christopher D Saffore, John Liu, Lani Wegrzyn, Chelsey Yang, Keith A Betts, Yan Wang, Alan D Irvine, Remo Panaccione
INTRODUCTION: Immune-mediated inflammatory diseases including rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), non-radiographic axial spondylarthritis (nr-axSpA), atopic dermatitis (AD), ulcerative colitis (UC), and Crohn's disease (CD) pose a substantial burden on patients and their quality of life. Upadacitinib is an orally administered, selective, and reversible Janus kinase inhibitor indicated for seven conditions, but data on its safety versus other active treatments are limited...
January 2, 2024: Advances in Therapy